NCT07761676 The Cohort Construction Project of Peking University Third Hospital
| NCT ID | NCT07761676 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Multiple Chronic Conditions (Unspecified) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2025-02-21 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2025-02-21 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The specific construction goals for this period include enrolling 100,000 individuals for dynamic follow-up, perfecting the biobank by collecting biological samples from 20,000 individuals, and gathering health questionnaire information from 30,000 people. The near-term goals emphasize the use of health check-up data combined with advanced artificial intelligence technologies to build disease prediction models and explore the association between retinal photographs and overall health status, which will assist in early screening and personalized interventions for high-risk populations. The medium- to long-term goals focus on biological age-related research, utilizing telomere length and multi-omics technologies to assess the differences between biological age and chronological age and analyze their key influencing factors. Data collection will be implemented through the health check-up centers of multiple campuses of PUTH.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years. Participants must be from group health examination populations who have undergone at least two consecutive health examinations at our Physical Examination Center. Exclusion Criteria: * Failure to provide informed consent. Incomplete data, including incomplete health examination self-administered questionnaires.
Contact & Investigator
Peng Wang, MMed
STUDY DIRECTOR
Peking University Third Hospital
Frequently Asked Questions
Who can join the NCT07761676 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Chronic Conditions (Unspecified). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07761676 currently recruiting?
Yes, NCT07761676 is actively recruiting participants. Contact the research team at tendytly@163.com for enrollment information.
Where is the NCT07761676 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07761676 clinical trial?
NCT07761676 is sponsored by Peking University Third Hospital. The principal investigator is Peng Wang, MMed at Peking University Third Hospital. The trial plans to enroll 100,000 participants.